Newton, MA — February 4, 2026 — Lumicell, Inc., a leader in developing innovative fluorescence-guided imaging technologies for cancer detection, today announced the appointment of Cheryl R. Blanchard, Ph.D., to

Global Team Will Launch Gastric Cancer Prevention Clinical Trial. CAUTION – Investigational device and new drug. Limited by Federal (or United States) law to investigational use.

Newton, MA — December 18th, 2025 — Lumicell, Inc., a leader in developing innovative fluorescence-guided imaging technologies for cancer detection, today announced a new collaboration with Learn Look Locate, a global

Pioneering real-time detection of cancer brings promise to enabling a more complete resection in gastrointestinal cancer surgery Newton, MA – Lumicell, Inc., a leader in developing innovative fluorescence-guided imaging technologies for

LumiSystem is the first and only fluorescence-guided imaging technology for breast cancer detection, enabling a more complete resection Newton, MA – Lumicell, Inc., a leader in developing innovative fluorescence-guided imaging

Independent director, Jim Alecxih, Chief Executive Officer of DH Medical joins Lumicell’s Board of Directors NEWTON, Mass., Jan. 6, 2025 – Lumicell, Inc., a privately held company focused on developing innovative

New data suggests that patients were satisfied with their cosmetic outcomes following the removal of suspicious tissue detected by fluorescence-guided imaging during lumpectomy surgery, and prefer to avoid a second

Permanent HCPCS code granted following U.S. FDA approval of LUMISIGHT™ (pegulicianine) and Lumicell™ Direct Visualization System (DVS), together referred to as LumiSystem™, with commercial availability in Q4 2024   NEWTON,

NEWTON, Mass., —Lumicell, Inc., a privately held company focused on developing innovative fluorescence-guided imaging technologies for cancerous tissue detection during surgery, is thrilled to announce its upcoming collaboration for an